Austen BioInnovation Institute, OMNOVA Solutions Partner to Reduce Healthcare Infections

Austen BioInnovation Institute and OMNOVA Solutions announced that teams from both organizations have started working on a pioneering project to explore the interactions between disinfectants and common health facility surfaces.

Advertisement

The goal of the project is to develop solutions that effectively minimize the risk of infection while preserving physical assets.

As possible solutions are developed, the teams begin work with Austen BioInnovation Institute’s Product Innovation and Commercialization Division on concept design, assessment of markets and intellectual property as well as regulatory implications.

The partnership includes technical support from the Clorox Professional Products Company and global health equipment and diagnostics manufacturer Midmark.

More Articles on Quality:

Despite Guidelines, Antibiotics Prescribed at High Rate for Bronchitis
New Pathogen-Identification Method Leads to Cost Savings: Study
Kaiser South Sacramento Patients Potentially Exposed to Whooping Cough

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.